Seminars in radiation oncology 2008-10
An overview of hypofractionation and introduction to this issue of seminars in radiation oncology.
Related Questions
New answer by Radiation Oncologist at Mayo Clinic, Rochester, MN (October 26, 2016)
I agree with @Bruce G. Haffty about the lack of evidence of increased toxicity in patients with BRCA1/2 or CHEK2 alterations (or PALB2 etc) and frequently refer to his im...